Coherus Oncology, Inc. short interest in 2019
In 2019, Coherus Oncology, Inc.'s disclosed short interest ran from 12.42% of shares outstanding on 15 Oct 2019 to 14.33% on 31 Dec 2019, a change of +1.91 percentage points. The year's high was 14.33% on 31 Dec 2019 and its low 12.42% on 15 Oct 2019, averaging 13.21% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.97 days on 31 Dec 2019. Full history: Coherus Oncology, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 12.42% (15 Oct 2019)
- End of year
- 14.33% (31 Dec 2019)
- Change
- +1.91 pp
- High
- 14.33% (31 Dec 2019)
- Low
- 12.42% (15 Oct 2019)
- Average
- 13.21%
- Highest days to cover
- 12.97 (31 Dec 2019)
- SEC filings marked
- 10
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 12.42% | 5.36 | 10-K filed, results (8-K), results (8-K), 10-Q filed, results (8-K), results (8-K), results (8-K), 10-Q filed |
| 31 Oct 2019 | 13.04% | 8.80 | |
| 15 Nov 2019 | 13.08% | 7.00 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 12.94% | 9.62 | |
| 13 Dec 2019 | 13.43% | 9.39 | |
| 31 Dec 2019 | 14.33% | 12.97 |
See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.